NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,100,000 | +33.3% | 4,962,657 | +13.2% | 2.37% | -1.9% |
| Q3 2020 | $2,325,000 | -23.7% | 4,384,199 | -1.4% | 2.42% | -59.0% |
| Q2 2020 | $3,046,000 | -13.4% | 4,447,026 | -5.2% | 5.90% | +58.6% |
| Q1 2020 | $3,518,000 | -52.1% | 4,690,146 | -3.5% | 3.72% | -27.2% |
| Q4 2019 | $7,337,000 | +10.1% | 4,858,889 | +7.9% | 5.11% | -20.9% |
| Q3 2019 | $6,663,000 | +3.9% | 4,502,301 | -9.4% | 6.47% | +46.5% |
| Q2 2019 | $6,413,000 | -45.5% | 4,971,014 | +10.2% | 4.42% | -34.8% |
| Q1 2019 | $11,775,000 | +69.5% | 4,511,504 | +7.2% | 6.77% | +11.0% |
| Q4 2018 | $6,947,000 | +528.7% | 4,210,153 | +1747.2% | 6.10% | +844.4% |
| Q3 2018 | $1,105,000 | -22.6% | 227,919 | +62.8% | 0.65% | -24.5% |
| Q4 2017 | $1,428,000 | -65.4% | 140,000 | -75.2% | 0.86% | -61.6% |
| Q2 2017 | $4,125,000 | – | 565,100 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |